In addition, the triggering receptor expressed on myeloid cell 2 (TREM2), a microglial surface receptor, is associated with microglial phenotype switching in neurological diseases such as AD, Parkinson’s disease, tauopathy, and ischemic stroke [17,18,19,20]. Here, TREM2 is linked to tauopathy.